SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-005582
Filing Date
2023-03-01
Accepted
2023-03-01 16:39:42
Documents
80
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K xene-20221231.htm   iXBRL 10-K 4272047
2 EX-4.4 xene-ex4_4.htm EX-4 53325
3 EX-23.1 xene-ex23_1.htm EX-23 7510
4 EX-31.1 xene-ex31_1.htm EX-31 17135
5 EX-31.2 xene-ex31_2.htm EX-31 16671
6 EX-32.1 xene-ex32_1.htm EX-32 13864
7 EX-32.2 xene-ex32_2.htm EX-32 13417
8 GRAPHIC img253168774_0.jpg GRAPHIC 58973
9 GRAPHIC img253168774_1.jpg GRAPHIC 42413
  Complete submission text file 0000950170-23-005582.txt   12638995

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xene-20221231_def.xml EX-101.DEF 193272
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xene-20221231.xsd EX-101.SCH 63609
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xene-20221231_lab.xml EX-101.LAB 539623
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xene-20221231_pre.xml EX-101.PRE 375046
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xene-20221231_cal.xml EX-101.CAL 58144
74 EXTRACTED XBRL INSTANCE DOCUMENT xene-20221231_htm.xml XML 2193502
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36687 | Film No.: 23694282
SIC: 2834 Pharmaceutical Preparations